DEA's failure to discipline distributor blamed for fueling opioid crisis
- The DEA allowed Morris & Dickson Co. to continue shipping highly addictive painkillers for nearly four years after a judge recommended it be stripped of its license for disregarding suspicious opioid orders.
- The delay raises concerns about how the revolving door between government and industry may be impacting the DEA’s ability to regulate companies blamed for the US opioid epidemic.
- Morris & Dickson, the fourth-largest US drug distributor, did not respond to requests for comment.
- Louis Milione, now DEA’s principal deputy administrator, did not respond to requests for comment on his previous work for Morris & Dickson.
- Morris & Dickson agreed to pay $22 million to resolve claims it failed to report suspicious hydrocodone and oxycodone orders, but the penalty came too late to stem the epidemic, experts argue.